ClinicalTrials.gov
public full text
Public Domain
Endothelin-Receptor Blockade in Coronary Heart Disease
Endothelin is a hormon that causes acute and chronic narrowing of heart vessels. The purpose of this study is to assess whether suppression of this activity by using two types of receptor antagonists can reduce this effect and thus improve blood supply of the heart muscle.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?#1096435
- Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms#907028
- Long Term Effects of Enalapril and Losartan on Genetic Heart Disease#898892
- Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?#311038
- Swiss Postpartum Hypertension Cohort#363524
Record · ID 1058240
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive